Coalition against Hepatitis in People of African Origin (CHIPO)

NYC Chapter – Quarterly Meeting

Wednesday, October 19th (3 – 4:30 PM)

hepfree.nyc/CHIPO-NYC / chipo.org

Meeting Highlights

Partners’ announcement and updates

  • CHIPO-NYC Updates:

Presentations

Hepatitis B Adult Vaccination Update

Natalie Taylor, Associate Director of Public Health, Dynavax Technologies, ntaylor@dynavax.com  

  • CDC Advisory Committee on Immunization Practices (ACIP) recommends that all adults 19-59 years of age receive the Hep B vaccine.
  • The age-based strategy of 19-59 years of age helps to identify patients at every clinical visit to receive Hep B vaccination. This is an opportunity to implement into electronic records systems an alert that will flag patients who are eligible for the Hep B vaccine.
  • HEPLISAV-B was approved in 2017 by the FDA then recommended by ACIP in 2018. This is a two-dose series – administered over four weeks.
  • Note that: HEPLISAV-B should not be administered to pregnant individuals.
  • You can sign up to get text reminders for your first or second dose.

Myths and Misconceptions about Hepatitis B among African Immigrants in the United States

Olorunseun O. Ogunwobi, MD, PhD, Director Hunter College Center for Cancer Health Disparities Research (CCHDR), Professor of Biological Sciences, Hunter College of The City University of New York, ogunwobi@genectr.hunter.cuny.edu

  • Non-Hispanic Blacks are the highest risk of Hep B with most of them residing in New York, Texas, or Maryland.
  • New York City has about two million immigrants from sub-Saharan Africa with 1.2% prevalence of Hep B infection in 2018.
  • It’s been reported that 9-11% of them are living with Hep B and as many as 70% or more have been exposed.
  • Researchers at CCHDR have focused on understanding Hep B screening and vaccination profiles among first-generation African immigrants.
  • CCHDR reported that as many as two-thirds of first-generation African immigrants have not been recommended screening and vaccination by their doctors.
    • Their knowledge of modes of transportation is also relatively low compared to their counterparts in the majority population.
    • Up to 66.67% of first-generation African immigrants do not receive screenings and vaccinations, because their providers have not recommended them. Additionally, they are less knowledgeable about modes of Hep B transmission.
  • FALSE common misconceptions, include:
    • There is no treatment for chronic Hep B,
    • Hep B is hereditary or genetic when it is passed from parent to child,
    • Hep B is contracted through kissing, shaking hands, sharing meals, etc.
    • It’s not safe to breastfeed if you have a Hep B,
    • Hep B is a fatal disease,
    • If an individual is vaccinated, they can still get infected with Hep B,
    • If someone has Hep B, they can’t get married or have children,
    • Hep B can be transmitted through mosquito bites,
  • To address Hep B stigma, interventions must include educating both medical professionals, and local policy makers
  • Memorial Sloan Kettering (MSK) health educators provide Hep B education sessions with Hep B testing and have found that community members are receptive when they feel empowered.

In attendance:

  1. Agatha Adigwe, Multicultural Aids Coalition, aadigwe@mac-boston.org
  2. Ayele Kessouagni, CUNY Intern/Consultant, NYC Department of Health and Mental Hygiene, akessouagni@health.nyc.gov
  3. Bright Ansah, Hep B Foundation, bansah90@gmail.com
  4. Bwambale Arafat, Public Health Scientist, Viral Hepatitis Community Partner, bwambalearafat@yahoo.com
  5. Farma Pene, Community Projects Coordinator, NYC Department of Health and Mental Hygiene, fpene@health.nyc.gov
  6. Fatima Omarufilo, Patient Navigator, Montefiore Medical Center, alabaran@montefiore.org
  7. Ganiat Sarumi Disu, RN, Viral Hepatitis Community Partner, gsarumi@gmail.com
  8. Ibrahima Sankare, Testing Assistant and Outreach, African Services Committee, ibrahimas@africanservices.org
  9. Jiehui (Joy) Zhu, Patient Navigator, Charles B. Wang Community Health Center, jizhu@cbwchc.org
  10. Justin Chen, Hep B Program Associate, Charles B. Wang Community Health Center, jchen@cbwchc.org
  11. Nadine Kela-Murphy, Clinical Practice Facilitation Program Manager, NYC Department of Health and Mental Hygiene, nkelamurphy@health.nyc.gov
  12. Natalie Taylor, Associate Director Public Health, Dynavax Technologies, ntaylor@dynavax.com
  13. Olorunseun O. Ogunwobi, Director, Hunter College Center for Cancer Health Disparities Research (CCHDR) | Associate Professor of Biological Sciences, CUNY – Hunter College, ogunwobi@genectr.hunter.cuny.edu
  14. Rokhaya Gueye, Testing Coordinator, African Services Committee, rokhayagueye31@gmail.com
  15. Sarah Ahmed, Communications and Community Engagement Coordinator, NYC Department of Health and Mental Hygiene, sahmed10@health.nyc.gov
  16. Shaibu Issa, Patients advocate, Organization for medical outreach to communities, shaibuissa60@gmail.com
  17. Toyin Omolola, CEO, DSI International Inc., dsiinternational14@gmail.com
  18. Umaima Khatun, Program Manager, NYC Department of Health and Mental Hygiene, ukhatun@health.nyc.gov

Join our network!
Subscribe to Meeting Invites or Newsletter

Last Updated on December 13, 2022 by HepFree NYC

©2025 HepFree.NYC. All rights reserved. Site by Lookit®

Log in with your credentials

Forgot your details?